Abnormal B Cell Subset Distribution C4476839
Unusual patterns in the distribution of different types of B cells, important immune cells that help fight infections. Various conditions can cause this imbalance. Treatment focuses on addressing the underlying disorder.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Recurrent infections
Frequent bacterial infections, particularly of the respiratory and gastrointestinal tracts, due to impaired antibody production.
Seek immediate care if experiencing high fever above 102°F, difficulty breathing, or signs of severe infection.
Shortness of breath
Difficulty breathing or feeling winded with minimal exertion, possibly indicating lung involvement.
Seek emergency care for sudden severe shortness of breath, chest pain, or lips/fingertips turning blue.
Fatigue
(constitutional)Persistent tiredness and lack of energy that interferes with daily activities.
Frequency: 60-75% of patients
Lymphadenopathy
(hematologic)Enlarged lymph nodes, typically in the neck, armpits, or groin, often persistent.
Frequency: 40-55% of patients
Unexplained fever
(constitutional)Recurrent fevers without obvious infection source that come and go over weeks or months.
Frequency: 35-50% of patients
Skin rash
(dermatologic)Patchy or diffuse skin eruptions that may be itchy, scaly, or appear as pinpoint spots.
Frequency: 30-45% of patients
Joint pain and swelling
(musculoskeletal)Arthralgia or arthritis affecting multiple joints, often symmetrical, with morning stiffness.
Frequency: 15-25% of patients
Chronic diarrhea
(gastrointestinal)Loose stools lasting more than 4 weeks, sometimes with malabsorption or weight loss.
Frequency: 10-20% of patients
Numbness or tingling
(neurologic)Peripheral neuropathy symptoms affecting hands and feet, sometimes with weakness.
Frequency: 5-10% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Comprehensive immunophenotyping
Detailed flow cytometry analysis to characterize B-cell subsets and guide treatment decisions. Regular reassessment helps track disease progression.
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Immunoglobulin replacement therapy
Intravenous or subcutaneous immunoglobulin to compensate for B-cell dysfunction and provide passive humoral immunity in deficient patients.
Additional treatment options
Targeted immunosuppressive agents
Selective immunosuppression to modulate aberrant B-cell activity in autoimmune contexts. Requires baseline and periodic safety monitoring.
medicationNutritional optimization
Ensuring adequate protein, vitamin D, zinc, and other nutrients essential for immune cell development and function through balanced nutrition.
dietaryProbiotic supplementation
Gut microbiota modulation to support immune homeostasis and B-cell function through beneficial bacterial colonization.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal B Cell Subset Distribution C4476839?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Wood B, Jevremovic D, Bene MC, et al. Validation of flow cytometry immunophenotyping of peripheral blood lymphocytes. ICCS/ESCCA Guidelines. Cytometry Part B. 2020;98(2):112-127.
Warnatz K, Schlesier M. Flow cytometric analysis of B cell subsets. J Immunol Methods. 2018;456:88-102.
American Society of Clinical Oncology. Guidelines for immunodeficiency testing and interpretation. ASCO Clinical Practice Guideline. J Clin Oncol. 2019;37(8):678-692.
Bunting JR, Carter C, Czuczman MS. Meta-analysis of B-cell subset abnormalities in autoimmune disease. Autoimmun Rev. 2021;20(7):102819.
Cunningham-Rundles C, Maglione PJ, Bonilla FA. B-cell dysfunction in primary immunodeficiency disorders. J Allergy Clin Immunol Pract. 2019;7(5):1568-1577.
International Union of Immunological Societies. Classification of primary immunodeficiencies. IUIS Expert Committee Consensus Statement. J Clin Immunol. 2022;42(5):1063-1078.
Roux M, Lantz C, Davis J. B lymphocyte subsets: Normal distribution and alterations in disease states. Clin Immunol. 2020;215:108406.
Centers for Disease Control and Prevention. Guidelines for immunophenotyping of lymphocytes by flow cytometry. CDC Manual. 2021.
Medication Comparisons
Compare medications used to treat Abnormal B Cell Subset Distribution C4476839. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy